2021
DOI: 10.1101/2021.04.20.440459
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Pivotal role of PDE10A in the integration of dopamine signals in mice striatal D1 and D2 medium-sized spiny neurones

Abstract: Dopamine in the striatum plays a crucial role in reward processes and action selection. Dopamine signals are transduced by D1 and D2 dopamine receptors which trigger mirror effects through the cAMP/PKA signalling cascade in D1 and D2 medium-sized spiny neurones (MSNs). Phosphodiesterases (PDEs), which determine the profile of cAMP signals, are highly expressed in MSNs, but their respective roles in dopamine signal integration remain poorly understood. We used genetically-encoded FRET biosensors to monitor at t… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
1
1

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(8 citation statements)
references
References 59 publications
(84 reference statements)
1
7
0
Order By: Relevance
“…This D2/D1 imbalance was consistent with PDE10A inhibitors mimicking the D2 antagonistic action of antipsychotic agents, which had sparked considerable interest in PDE10A as a potential therapeutic target to treat schizophrenia (Kehler and Nielsen, 2011;Schülke and Brandon, 2017;Harada et al, 2020). So far, this hope has not met clinical success (Menniti et al, 2020), possibly because inhibiting such an essential signaling enzyme profoundly destabilizes signal integration in MSNs (Mota et al, 2021). Compared to PDE10A, PDE2A and PDE4 display much lower affinity for cAMP and therefore preferentially regulate high cAMP concentration.…”
Section: Pde10a: a Major Regulator Of Camp/pka Signals In The Striatummentioning
confidence: 67%
See 4 more Smart Citations
“…This D2/D1 imbalance was consistent with PDE10A inhibitors mimicking the D2 antagonistic action of antipsychotic agents, which had sparked considerable interest in PDE10A as a potential therapeutic target to treat schizophrenia (Kehler and Nielsen, 2011;Schülke and Brandon, 2017;Harada et al, 2020). So far, this hope has not met clinical success (Menniti et al, 2020), possibly because inhibiting such an essential signaling enzyme profoundly destabilizes signal integration in MSNs (Mota et al, 2021). Compared to PDE10A, PDE2A and PDE4 display much lower affinity for cAMP and therefore preferentially regulate high cAMP concentration.…”
Section: Pde10a: a Major Regulator Of Camp/pka Signals In The Striatummentioning
confidence: 67%
“…In addition, PDE10A shows a prominent functional role in the regulation of the cAMP/PKA response in both D1 and D2 MSNs (Mota et al, 2021), as shown by cAMP measurements in striatal brain slices. This work showed that PDE10A is required to degrade cAMP to a sufficiently low level to allow for PKA de-activation: when PDE10A is blocked, dopamine signals can no longer be detected at the level of PKA.…”
Section: Pde10a: a Major Regulator Of Camp/pka Signals In The Striatummentioning
confidence: 82%
See 3 more Smart Citations